In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy - Response to Prentice et al [6]

British Journal of Haematology

Volumn 132, Issue 5, 2006, Pages 658-659

  Falagas, Matthew E ^a,b   Vardakas, Konstantinos Z ^a   Michalopoulos, Argyris ^a  

^a HENRY DUNANT HOSPITAL   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amphotericin B; Azole; Bone marrow transplantation; Granulocytopenia; Polyene

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; VINCA ALKALOID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ASPERGILLOSIS; ASPERGILLUS; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; INFECTION RISK; LETTER; META ANALYSIS; NEUTROPENIA; PRIORITY JOURNAL; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 33644898104     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.05968.x     Document Type: Letter

References (8)

1. Bow E.J. Laverdiere M. Lussier N. Rotstein C. Cheang M.S. Ioannou S. 2002 Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials Cancer 94 3230 3246
2. Glasmacher A. Prentice A. Gorschluter M. Engelhart S. Hahn C. Djulbegovic B. Schmidt-Wolf I.G. 2003 Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients Journal of Clinical Oncology 21 4615 4626
3. Gotzsche P.C. Johansen H.K. 1997 Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia British Medical Journal 314 1238 1244
4. Kanda Y. Yamamoto R. Chizuka A. Hamaki T. Suguro M. Arai C. Matsuyama T. Takezako N. Miwa A. Kern W. Kami M. Akiyama H. Hirai H. Togawa A. 2000 Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials Cancer 89 1611 1625
5. Marr K. Carter R.A. Boeckh M. Martin P. Corey L. 2002 Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors Blood 100 4358 4366
6. Martino R. Subira M. Rovira M. Solano C. Vazquez L. Sanz G.F. Urbano-Ispizua A. Brunet S. De la Camara R. 2002 Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients British Journal of Haematology 116 475 482
7. Morgenstern G.R. Prentice A.G. Prentice H.G. Ropner J.E. Schey S.A. Warnock D.W. 1999 A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. UK Multicentre Antifungal Prophylaxis Study Group British Journal of Haematology 105 901 911
8. Vardakas K.Z. Michalopoulos A. Falagas M.E. 2005 Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials British Journal of Haematology 131 22 28